XML 33 R26.htm IDEA: XBRL DOCUMENT v3.24.3
Stock Award Plans and Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense

The Company recognized stock-based compensation expense related to the issuance of stock option awards and restricted stock units to employees, non-employees and directors in the statements of operations as follows:

 

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of goods sold

 

$

22,805

 

 

$

24,222

 

 

$

35,601

 

 

$

66,815

 

Research and development

 

 

30,599

 

 

 

11,362

 

 

 

63,562

 

 

 

(24,056

)

Selling, clinical and marketing

 

 

41,925

 

 

 

50,984

 

 

 

95,237

 

 

 

142,432

 

General and administrative

 

 

228,856

 

 

 

243,826

 

 

 

358,180

 

 

 

596,322

 

Total

 

$

324,185

 

 

$

330,394

 

 

$

552,580

 

 

$

781,513